SIPAI HEALTH (00314) repurchased 50,000 shares at a cost of approximately HKD 78,800 on September 9.
SIPA Health (00314) announced that on September 9, 2026, it spent approximately HKD 78,800 to repurchase 50,000 shares.
SIPAI HEALTH (00314) announced that on September 9, 2026, it spent approximately HKD 78,800 to repurchase 50,000 shares.
Related Articles
SIMCERE PHARMA (02096) spent HKD 10.7033 million on September 9 to repurchase 929,000 shares.
CSPC PHARMA (01093): The long-acting injection of Rotigotine (SYH 9087 injection) has received clinical trial approval in China.
Anjoy Foods Group (02648): Ding Shaoxiong has been nominated as a candidate for independent non-executive director.
SIMCERE PHARMA (02096) spent HKD 10.7033 million on September 9 to repurchase 929,000 shares.
CSPC PHARMA (01093): The long-acting injection of Rotigotine (SYH 9087 injection) has received clinical trial approval in China.
Anjoy Foods Group (02648): Ding Shaoxiong has been nominated as a candidate for independent non-executive director.
RECOMMEND
